Multidrug-resistant pulmonary tuberculosis
Carregando...
Citações na Scopus
Tipo de produção
article
Data de publicação
2017
Título da Revista
ISSN da Revista
Título do Volume
Editora
AME PUBL CO
Autores
Citação
VIDEO-ASSISTED THORACIC SURGERY, v.2, article ID UNSP 72, 5p, 2017
Resumo
The advent of effective antituberculous medication has greatly diminished the role of surgery in the management of tuberculosis (TB). More recently, diseases that are resistant to medical treatment have emerged as a major challenge. Multidrug-resistant tuberculosis (MDRTB) is defined as resistance to two or more drugs, including rifampin and isoniazid. In such cases, high relapse rates with medical therapy alone have been reported and adjuvant surgical resection has been proposed as a therapeutic option in selected patients. Although many studies have shown good results with this surgical strategy, the role of minimally invasive surgery in this scenario has yet to be established. Here we review the indications of surgical resection for MDRTB and the role of minimally invasive surgery for infectious / inflammatory diseases of the lungs.
Palavras-chave
Tuberculosis (TB), multidrug-resistant, thoracic surgery, video-assisted, robotic surgical procedures
Referências
- Alexander J, 1937, COLLAPSE THERAPY TUB
- Atkins BZ, 2007, ANN THORAC SURG, V84, P1107, DOI 10.1016/j.athoracsur.2007.05.013
- Bendixen M, 2016, LANCET ONCOL, V17, P836, DOI 10.1016/S1470-2045(16)00173-X
- Blumberg Henry M, 2003, Am J Respir Crit Care Med, V167, P603
- Burfeind WR, 2010, EUR J CARDIO-THORAC, V37, P827, DOI 10.1016/j.ejcts.2009.10.017
- Calligaro GL, 2014, J THORAC DIS, V6, P186, DOI 10.3978/j.issn.2072-1439.2013.11.11
- Cerfolio RJ, 2011, J THORAC CARDIOV SUR, V142, P740, DOI 10.1016/j.jtcvs.2011.07.022
- Dylewski MR, 2011, SEMIN THORAC CARDIOV, V23, P36, DOI 10.1053/j.semtcvs.2011.01.005
- Hartwig MG, 2010, ANN THORAC SURG, V89, pS2098, DOI 10.1016/j.athoracsur.2010.02.102
- ISEMAN MD, 1990, AM REV RESPIR DIS, V141, P623, DOI 10.1164/ajrccm/141.3.623
- ISEMAN MD, 1993, NEW ENGL J MED, V329, P784
- Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115
- Johnston JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006914
- Kempker RR, 2012, LANCET INFECT DIS, V12, P157, DOI 10.1016/S1473-3099(11)70244-4
- LANGSTON HT, 1966, ANN SURG, V164, P567
- McKenna RJ, 2006, ANN THORAC SURG, V81, P421, DOI 10.1016/j.athoracsur.2005.07.078
- Mitchell JD, 2012, ANN THORAC SURG, V93, P1033, DOI 10.1016/j.athoracsur.2012.01.012
- MORICE RC, 1992, CHEST, V101, P356, DOI 10.1378/chest.101.2.356
- Moura de Gouvea F, 2017, ASVIDE, V4, P444
- NAEF AP, 1993, ANN THORAC SURG, V55, P1375, DOI 10.1016/0003-4975(93)91073-V
- Onaitis MW, 2006, ANN SURG, V244, P420, DOI 10.1097/01.sla.0000234892.79056.63
- Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6
- Park BJ, 2012, J THORAC CARDIOV SUR, V143, P383, DOI 10.1016/j.jtcvs.2011.10.055
- Partners In Health, 2003, PIH GUID MED MAN MUT, P29
- Paul S, 2010, J THORAC CARDIOV SUR, V139, P366, DOI 10.1016/j.jtcvs.2009.08.026
- Petersen RP, 2007, ANN THORAC SURG, V83, P1245, DOI 10.1016/j.athoracsur.2006.12.029
- Pomerantz BJ, 2001, J THORAC CARDIOV SUR, V121, P448, DOI 10.1067/mtc.2001.112339
- Veronesi G, 2010, J THORAC CARDIOV SUR, V140, P19, DOI 10.1016/j.jtcvs.2009.10.025
- Villamizar NR, 2009, J THORAC CARDIOV SUR, V138, P419, DOI 10.1016/j.jtcvs.2009.04.026
- Weber A, 2001, EUR J CARDIO-THORAC, V20, P443, DOI 10.1016/S1010-7940(01)00689-3
- WHO, 2008, GUID PROGR MAN DRUG
- WHO, 2013, MULT RES TUB MDR TB
- Yim APC, 1996, CHEST, V109, P554, DOI 10.1378/chest.109.2.554
- Zhang P, 2011, ANN THORAC SURG, V91, P239, DOI 10.1016/j.athoracsur.2010.08.035